
Insulet to Showcase its Recently-Launched Omnipod® DASH™ System and Present Seven Scientific Abstracts at the American Diabetes Association's 79th Scientific Sessions
No-Cost Personal Diabetes Manager, No Four Year Lock-in Period,
and New User Interface Allow for Smooth Transition from
The Company will also present new research results for its innovation pipeline, including Insulet’s Omnipod Horizon™ Automated Insulin Delivery System evidencing its safety and performance in young children aged two- to six- years with type 1 diabetes, as well as additional real-world data on long-term clinical outcomes from over 20,000 Omnipod System users, which further support the benefits of the Omnipod System.
“We are thrilled to be in full market release with our new Omnipod DASH System, which is designed to be the best and easiest-to-use insulin delivery system available,” said Bret Christensen, Executive Vice President and Chief Commercial Officer. “We know our customers are counting on us to deliver the highest quality products and support, which is why we are pleased to present compelling new research demonstrating the significant and continued progress we are making on our innovation pathway.”
For more about Insulet’s future innovation pipeline, please visit myomnipod.com/innovation.
A schedule of
Time | Presentation | Location | ||
Saturday, June 8 | ||||
11:30 AM – 12:30 PM |
1453-P Glycemic Profiles and Insulin Use in 2,313 Medicare-Eligible Older Adults with Diabetes Using the Omnipod® Insulin Management System with Cloud-Based Data Management
Jennifer E. Layne, Jialun He, Jay Jantz, Yibin Zheng, Eric Benjamin, Trang T. Ly |
Poster Hall | ||
Sunday, June 9 | ||||
12:00 – 1:00 PM |
1042-P Real-World Treatment Patterns and Glycemic Profiles of 1,217 Adults with Type 2 Diabetes Using the Omnipod® Insulin Management System with Cloud-Based Data Management
Jennifer E. Layne, Jay Jantz, Jialun He, Yibin Zheng, Eric Benjamin, Trang T. Ly |
Poster Hall | ||
12:00 – 1:00 PM |
1043-P Glycemic Profiles and Treatment Patterns: Real-World Data from 8,020 Adults with Type 1 Diabetes Using the Omnipod® Insulin Management System with Cloud-Based Data Management
Jennifer E. Layne, Jialun He, Jay Jantz, Yibin Zheng, Eric Benjamin, Trang T. Ly |
Poster Hall | ||
12:00 – 1:00 PM |
1055-P Glucose Management Indicator Results from Real-World Data of 1,838 Patients with Type 1 Diabetes Using the Omnipod® Insulin Management System with Continuous Glucose Monitoring and Cloud-Based Data Management
Jennifer E. Layne, Jay Jantz, Yibin Zheng, Jialun He, Eric Benjamin, Trang T. Ly |
Poster Hall | ||
12:00 – 1:00 PM |
1061-P Effect of the Omnipod® Insulin Management System on Glycemic Control in Adults with Type 1 Diabetes Previously Treated with MDI or CSII
Sanjeev N. Mehta, Davida F. Kruger, Bruce W. Bode, Jennifer E. Layne, Bonnie Dumais, Jack R. Gallagher, Trang T. Ly |
Poster Hall | ||
6:00 – 6:15 PM |
215-OR Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Young Children Aged 2-6 Years with Type 1 Diabetes
Bruce A. Buckingham, Gregory P. Forlenza, Jennifer Sherr, Alfonso Galderisi, Laya Ekhlaspour, Joon Bok Lee, Jason B. O’Connor, Bonnie Dumais, Lauren M. Huyett, Jennifer E. Layne, Trang T. Ly |
S-10 (South, Exhibition Level) Oral Presentation | ||
Monday, June 10 | ||||
12:00 – 1:00 PM |
1357-P Real-World Glycemic Profiles and Insulin Use Patterns of 9,914 Pediatric and Adolescent Patients with Type 1 Diabetes Using the Omnipod® Insulin Management System with Cloud-Based Data Management
Jennifer E. Layne, Yibin Zheng, Jialun He, Jay Jantz, Eric Benjamin, Trang T. Ly |
Poster Hall | ||
About the Omnipod DASH System:
Insulet’s Omnipod DASH System was designed to serve as the foundation
for the Company’s future innovation. Designed with patient discretion
and convenience in mind, the Omnipod DASH is a continuous insulin
delivery system consisting of two simple components: a tubeless,
waterproof*, Bluetooth® wireless technology Pod (pump) that
holds up to 200 units of U-100 insulin and a modern, color touch-screen
Personal Diabetes Manager (PDM) that controls the Pod. The Omnipod DASH
System will have a suite of optional mobile apps for users, caregivers
and HCPs to help simplify diabetes management. The Omnipod DASH System,
which received
For more information, please visit: www.insulet.com and www.myomnipod.com.
Forward-Looking Statement:
This press release may contain forward-looking statements
concerning Insulet's expectations, anticipations, intentions, beliefs or
strategies regarding the future. These forward-looking statements are
based on its current expectations and beliefs concerning future
developments and their potential effects on Insulet. There can be no
assurance that future developments affecting Insulet will be those that
it has anticipated. These forward-looking statements involve a number of
risks, uncertainties (some of which are beyond its control) or other
assumptions that may cause actual results or performance to be
materially different from those expressed or implied by these
forward-looking statements, and other risks and uncertainties described
in its Annual Report on Form 10-K, which was filed with the Securities
and Exchange Commission in
*The Pod has a waterproof IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof.
© 2019
View source version on businesswire.com: https://www.businesswire.com/news/home/20190606005059/en/
Source:
Investor and Corporate Communications Contact:
Deborah
R. Gordon, 978-600-7717
Vice President, Investor Relations and
Corporate Communications
dgordon@insulet.com
Consumer Contact:
Natalie Toomey, 978-600-7421
Marketing
Manager, Global Public Relations & Field Programs
ntoomey@insulet.com